Overall, the most represented SOC among the reported events were general manifestations, consistent with the manifestations observed during IL-2 injection, such as asthenia, flu-like syndrome and pain at site injection, followed by gastrointestinal disorders. Here, IL2 is linked to digestive system disorder.